x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines. Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.

science life sciences

All Episodes

58:30

Driving growth and removing waste for big pharma

Molecule to Market: Inside the outsourcing space ·

2025/09/26

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Matt Lowe, CEO at performance.io/Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Matt, covering: Seeing a niche in SEO, within the healthcare space... and opting to take a risk and jump our of big pharma. Why healthcare agency models are built for agencies, not pharma. The mass wastage of big pharma spend when it comes to the commercial

en

42:41

Riding the ups and downs of entrepreneurship

Molecule to Market: Inside the outsourcing space ·

2025/09/19

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michael Scholl, Chief Executive Officer and Co-Founder at Leukocare.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Michael, covering: The influences, and potential for impact that led him down a path of entrepreneurship. Chronicling the ups and downs of over 20 years in business at Leukocare. Pivoting to be a specialist CRO/CDMO with a

en

55:11

Unlocking CDMO growth via commercial excellence

Molecule to Market: Inside the outsourcing space ·

2025/09/12

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kaan-Fabian Kekec, Partner in Healthcare and Life Sciences at Simon-Kucher.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kaan, covering: Being on the sunny side of consulting, and helping clients unlock growth. What makes a key strategic partnership both from a CDMO, and a sponsor perspective. The taboo subject of pricing and how it

en

53:20

Pharma services market sentiment at the midpoint of 25

Molecule to Market: Inside the outsourcing space ·

2025/09/05

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adam Siebert, Managing Director and Partner at L.E.K. Consulting.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adam, covering: Adam's journey from academic to commercial, and what helped him transition into 'life science enablers". How pandemic demand has left our sector with a huge over capacity issue and market imbalance. Some

en

56:07

Doc to CEO - 40 years of reinvention in biopharma

Molecule to Market: Inside the outsourcing space ·

2025/08/29

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Stephen Dilly, Chairman, President and Chief Executive Officer at Codexis.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Stephen, covering: His journey of almost 40 years in the industry, including 20 years as a CEO. Leading two therapeutic companies to two, successful, $billion+ exits... Not making snap judgements and instant opinions

en

43:32

Meet the new boss of CPHI Europe

Molecule to Market: Inside the outsourcing space ·

2025/08/21

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tara Dougal, Event Director - Pharma (CPHI Europe).Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tara, covering: How CPHI has changed over the last decade of Tara being involved in the show. The challenge of dealing with the volume of over 60k people turning up for three days at a major European city. Being tasked with running one of

en

52:52

30 years on the rollercoaster of clinical trials

Molecule to Market: Inside the outsourcing space ·

2025/08/15

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Riches, Vice President, Clinical Solutions at Citeline.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Claire, covering: Being involved in the clinical development and commercial launch of a little mega-blockbuster, called... Viagra. Her first exposure to outsourcing at a small biotech, and the importance of partnerships in

en

57:16

The rain-making, 2X exit founder

Molecule to Market: Inside the outsourcing space ·

2025/08/08

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Andrea Wagner, CEO at PharmaPhixx.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Andrea, covering: Building a 'not very pretty' business, to an eventual exit after 10 years The reluctant founding of Berkshire Sterile Manufacturing (Now Sharp)...making new mistakes on her encore journey of growth and a second exit Why company leaders

en

50:47

The Indian CEO driving change

Molecule to Market: Inside the outsourcing space ·

2025/08/01

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ankit Gupta, CEO at Tenshi Kaizen.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ankit, covering: His accidental journey into pharma, and then pharma manufacturing How his exposure to the pharma value chain via consulting led to numerous roles in the sector, including a critical one at Strides Pharma Sciences Limited and other group

en

57:37

40 years, 6 exits - a CEO addict

Molecule to Market: Inside the outsourcing space ·

2025/07/25

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adam Sherlock, CEO at Qinecsa.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adam, covering: How he developed his professional CEO skills over the years to complement is entrepreneurial spirit The combination of micro and macro factors that help determine when the right time is to go to market, and sell The importance of your gut

en

01:16:29

CDMO Live insights: Industry leaders on the future of...

Molecule to Market: Inside the outsourcing space ·

2025/07/18

In this special episode of Molecule to Market, recorded at this year’s CDMO Live in Rotterdam, industry leaders come together to assess the evolving state of the contract development and manufacturing sector. Raman is the panel moderator, joined by: Gil Roth - PBOA Dr. Jim Li - BioDuro Sundia Kaan-Fabian Kekec - Simon-Kucher They unpack cautious optimism in the face of lingering market uncertainties and geopolitical tension, you’ll hear: How CDMOs are adapting to early-stage funding strain and

en

49:02

The learning curve of a biotech founder/CSO

Molecule to Market: Inside the outsourcing space ·

2025/07/11

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Hella Kohlhof, CSO at Immunic.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Hella, covering: How the 'waste of two molecules' led to the spin-out creation of Immunic Therapeutics. The perfect blend of a founding team willing to split responsibility, learn and have a go. Ending up as a Nasdaq-listed company via a reverse merger... and

en

44:52

The cancer Doc, driven by impact

Molecule to Market: Inside the outsourcing space ·

2025/07/04

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tim Showalter, Radiation Oncologist, Founder and Chief Medical Officer at ArteraAI.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tim, covering: The attraction of radiation oncology at med school and his fascination with clinical trials His frustration with tools for cervical cancer patients led to the creation of a medical device

en

46:03

The GM focused on inhaled & nasal drugs

Molecule to Market: Inside the outsourcing space ·

2025/06/27

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gemma Budd, General Manager at Nanopharm.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gemma, covering: Why being in an overlay strategic, future-focused role led her to make the tough decision to move on Identifying the joy of solving problems for customers in service-based businesses Why her holistic experience led to the GM

en

50:29

The impact of a CEO who loves to work

Molecule to Market: Inside the outsourcing space ·

2025/06/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeanne Taylor Hecht, Chief Executive Officer and Chairwoman at Lexitas.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jeanne, covering: How Jeanne's various roles have equipped her to become a more rounded CEO and board member. How a stint in Asia led Jeanne to develop her strategy playbook, including the importance of the client's

en

55:43

From brink of bankruptcy to boom

Molecule to Market: Inside the outsourcing space ·

2025/06/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Garren Hillow, Executive Coach and Author.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Garren, covering: Why not being a PhD scientist really helped him in selling science How recruiting for glory enabled him to hire the best people on the planet Buying a CRO business and getting comfortable with the risk of bankruptcy Going all in on

en

50:10

The CEO addicted to challenge

Molecule to Market: Inside the outsourcing space ·

2025/06/06

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Angelo Gatto, CEO at Chanelle Pharma.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Angelo, covering: Why he chose to follow a big pharma divestment into the CDMO industry. The tricky transition from big pharma technical to commercial CDMO BD when he had the view of "I don't like sales people"! How commercial trust is developed through

en

51:16

The COO leveraging the ‘power of we’

Molecule to Market: Inside the outsourcing space ·

2025/05/30

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Christiane Bardroff, COO of Rentschler Biopharma SE.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Christiane, covering: The importance of "knowing what you're talking about" to build confidence Being asked to build and commission an automated €800m bioprocessing plant at Teva The draw of a family-owned CDMO business servicing 170

en

51:08

The pharma CEO focused on US commercial growth

Molecule to Market: Inside the outsourcing space ·

2025/05/23

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adriana Herrera, CEO at Pierre Fabre Pharmaceuticals (USA).Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adriana, covering: Why Big Pharma is such a great training ground for future pharma leaders, and how a period living and working in Mexico defined her leadership style The reality of being purchased by a big pharma like Gilead, and

en

43:07

The Spanish solid state specialist

Molecule to Market: Inside the outsourcing space ·

2025/05/16

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Victor Diaz, Co-Founder of Solitek.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Victor, covering: Falling in love with medicinal chemistry and ending up experiencing the culture shock of North East England! Why Victor fell in love with working on a variety of projects at CROs/CDMOs The benefits of solid state chemistry and its value

en

239 results

Similar Podcasts

X Minus 1 - Old Time Radio Show

Inception Point Ai

Science, Spoken

WIRED

This Week in Space (Audio)

TWiT

DarshanTalks Podcast

Darshan Kulkarni

The Best of Coast to Coast AM

iHeartPodcasts and Coast to Coast AM